UNITED THERAPEUTICS Corp (UTHR) › Cost of RevenueUNITED THERAPEUTICS Corp (UTHR) — Cost of RevenueAnnual figures by period end, from SEC filings.2016-12-31: $72.70M2017-12-31: $105.70M2018-12-31: $198.70M2019-12-31: $117.60M2020-12-31: $108.10M2021-12-31: $122.50M2022-12-31: $151.60M2023-12-31: $257.50M2024-12-31: $309.70M2025-12-31: $384.40M$384.40M2016-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$384.40M+24.1%2026-02-25From 2025-01-012024-12-31$309.70M+20.3%2026-02-25From 2024-01-012023-12-31$257.50M+69.9%2026-02-25From 2023-01-012022-12-31$151.60M+23.8%2025-02-26From 2022-01-012021-12-31$122.50M+13.3%2024-02-21From 2021-01-012020-12-31$108.10M-8.1%2023-02-22From 2020-01-012019-12-31$117.60M-40.8%2022-02-24From 2019-01-012018-12-31$198.70M+88.0%2021-02-24From 2018-01-012017-12-31$105.70M+45.4%2020-02-26From 2017-01-012016-12-31$72.70M—2019-02-27From 2016-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)